That approval was for children five and older
In contrast to earlier GLP-1 receptor agonists, which primarily target appetite suppression and glycemic improvement, GLP-3 leverages GCG receptor activation to stimulate lipolysis and elevate basal metabolic rate, thereby contributing to a more pronounced and sustained reduction in adiposity as observed in research models
Results vary based on individual factors including age, baseline hormone levels, diet, exercise, and adherence to protocol
You're not a fit if you're looking for something that doesn't require a clinical evaluation at all, or if you live in one of the four states HumeCare says it doesn't currently serve
PMID: 20 NarwaniVSwafeLStavrakaCDhatariyaK
Annu Rev Pathol 2010;5, 99-118, doi:10.1146/annurev-pathol-121808-102144